ESR1 and breast cancer: Since we detect a significant correlation between NCOA3 overexpression and PLAC1 expression in ERα-positive breast cancer patients this adds to the relevance of understanding the role of PLAC1 in the NCOA3/ERα-signaling pathway and might open new therapeutic concepts for breast cancer.